Corporate insider profile
Michael H. Mulroy Insider Trades
Michael H. Mulroy has reported 1 open-market purchase on SEC Form 4 and is a net buyer of $26,100 across 1 company. The most recent open-market transaction was reported on Nov 17, 2026. Source: SEC Form 4 filings.
Latest reported as Director of Lineage Cell Therapeutics, Inc. (LCTX).
SEC-reported filing activity is provided for research purposes and is not investment advice.
- Purchase filings
- 1
- Reported companies
- 1
- Net open-market value
- $26,100
- Latest transaction
- Nov 17, 2026
Affiliated corporations
Reported company relationships
Transaction history
Open-market Transactions
Common questions
Michael H. Mulroy insider trading FAQ
- Is Michael H. Mulroy buying or selling stock?
- Across all SEC Form 4 open-market filings on record, Michael H. Mulroy is a net buyer of $26,100, with 1 open-market purchase reported. The latest transaction was reported on Nov 17, 2026.
- Which companies does Michael H. Mulroy report insider trades for?
- Michael H. Mulroy has reported open-market trades in Lineage Cell Therapeutics, Inc. (LCTX). The latest SEC-reported relationship is Director of Lineage Cell Therapeutics, Inc. (LCTX).
- Where does Michael H. Mulroy's insider trading data come from?
- Watch Insiders reads the SEC Form 4 filings submitted to EDGAR under reporting owner CIK 1509725, and refreshes this page daily.
